// App-Quantinova.ai

PB2013 : TECLISTAMAB COMPARED WITH REAL-WORLD THERAPIES IN PATIENTS WITH TRIPLE-CLASS EXPOSED RELAPSED/REFRACTORY MULTIPLE MYELOMA

Researchers

Presenter

  • Amrita Krishnan

Principal Investigators

  • Ajay K. Nooka

  • Ajai Chari

  • Alfred Garfall

  • Thomas Martin

  • Sandhya Nair

  • Xiwu Lin

  • Keqin Qi

  • Anil Londhe

  • Lixia Pei

  • Eric Ammann

  • Rachel Kobos

  • Jennifer Smit

  • Trilok Parekh

  • Mary Slavcev

  • Saad Usmani

Medical Centers

  • Mount Sinai School of Medicine, New York, NY

  • University of California, San Francisco, United States

  • Janssen Pharmaceutica NV, Beerse, Belgium

  • Janssen Pharmaceutica NV, Beerse, Belgium

  • Memorial Sloan-Kettering Cancer Center, New York, NY, United States

  • Memorial Sloan-Kettering Cancer Center, New York, NY, United States

  • Janssen Global Services, LLC, Horsham, PA

  • Mount Sinai School of Medicine,New York,Vereinigte Staaten

  • Development,Bridgewater,Verenigde Staten

  • Mount Sinai School of Medicine,New York,Vereinigte Staaten

  • Development, LLC,Raritan, NJ,États-unis

  • Janssen Global Services,Horsham,Stati Uniti

  • Hematology Oncology, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA

  • University of California, San Francisco, CA

  • Janssen Pharmaceutica NV, Beerse, Belgium

  • Janssen Global Services, Raritan, NJ

  • Memorial Sloan Kettering Cancer Center, Port Washington, NY

  • Development,Raritan, NJ,Vereinigte Staaten

  • Winship Cancer Institute of Emory University, Atlanta, GA

  • Janssen Global Services,Horsham,United States

  • Memorial Sloan Kettering Cancer Center, Port Washington, NY

  • Janssen Pharmaceutica NV, Beerse, Belgium

  • Memorial Sloan Kettering Cancer Center, Port Washington, NY

  • Development,Bridgewater,Estados Unidos

  • Development, Raritan, NJ

  • City of Hope Cancer Center,Duarte,United States

  • Development, LLC,Spring House, PA,Estados Unidos

  • Janssen Global Services,Horsham,United States

  • City of Hope Cancer Center,Duarte,United States

  • Janssen Global Services,Raritan,Estados Unidos

  • Development,Bridgewater, NJ,États-unis

  • Development, LLC,Titusville, NJ,Stati Uniti

  • Janssen Global Services,Horsham,Stati Uniti

  • Janssen Global Services, Raritan, NJ, United States

  • Janssen Pharmaceutica NV, Beerse, Belgium

  • Development,Bridgewater, NJ,USA

  • Janssen Research &amp

  • Janssen Global Services,Raritan,Estados Unidos

  • City of Hope Comprehensive Cancer Center,Duarte, CA,États-unis

  • Winship Cancer Institute, Emory University Hospital,Atlanta, GA,Vereinigte Staaten

  • Mount Sinai School of Medicine,New York, NY,Estados Unidos

  • Development, LLC,Spring House,United States

  • Development, IHI RWE,Titusville, NJ,United States

  • Mount Sinai Icahn School of Medicine, New York, New York, United States

  • City of Hope Cancer Center,Duarte,United States

  • Janssen Global Services, Raritan, NJ, United States

  • University of California San Diego, CA, United States

  • City of Hope Comprehensive Cancer Center,Duarte, CA,États-unis

  • Mount Sinai School of Medicine, New York, NY

  • Development,Titusville, NJ,Vereinigte Staaten

  • Winship Cancer Institute, Emory University,Atlanta,États-unis

  • Memorial Sloan Kettering Cancer Center,New York ,États-unis

  • Development,Raritan,United States

  • Development,Titusville, NJ,Vereinigte Staaten

  • Winship Cancer Institute of Emory University,Atlanta, GA,Vereinigte Staaten

  • Development,Titusville,Estados Unidos

  • Janssen Global Services,Horsham,United States

  • Janssen Pharmaceutica NV, Beerse, Belgium

  • City of Hope National Comprehensive Cancer Center, Duarte, CA

  • Winship Cancer Institute, Emory University,Atlanta,États-unis

  • Memorial Sloan-Kettering Cancer Center, New York, NY, United States

  • University of California,San Francisco,Stati Uniti

  • Development, Spring House, PA

  • Development, LLC,Spring House,United States

  • Abramson Cancer Center and University of Pennsylvania,Philadelphia, PA,États-unis

  • Development, LLC,Titusville, NJ,Stati Uniti

  • Winship Cancer Institute of Emory University, Atlanta, GA

  • University of California, San Francisco, United States

  • Janssen Global Services,Horsham, PA,Estados Unidos

  • University of California, San Francisco, CA

  • Development, LLC,Spring House,United States

  • Mount Sinai School of Medicine, New York, NY

  • Development,Raritan,Estados Unidos

  • Development,Bridgewater,United States

  • Development,Titusville, NJ,USA

  • Janssen Global Services, Raritan, NJ, United States

  • City of Hope Comprehensive Cancer Center,Duarte, CA,États-unis

  • Development,Spring House,États-unis

  • Development,Raritan, NJ,Vereinigte Staaten

  • Development,Bridgewater, NJ,Stati Uniti

  • University of California, San Francisco, CA

  • Janssen Global Services,Raritan,Estados Unidos

  • Development,Bridgewater,Verenigde Staten

  • Development,Spring House, PA,Stati Uniti

  • Winship Cancer Institute, Emory University,Atlanta,États-unis

  • Development,Raritan,Stati Uniti

Locations

  • United States

  • Belgium

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Multiple Myeloma

Biomarkers

  • N/A

Drug/Treatment

  • Techniclone TNT

Outcome

  • N/A

Study Design

  • Multinational

Phase

  • I/II

Study Id's

  • NCT04557098

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved